K. Hayashi

发表

Bioconversion of vitamin D to its active form by bacterial or mammalian cytochrome P450.

K. Yasuda, H. Sugimoto, S. Ikushiro, 2011, Biochimica et biophysica acta.

Sequential hydroxylation of vitamin D2 by a genetically engineered CYP105A1.

K. Yasuda, K. Yasukawa, S. Ikushiro, 2016, Biochemical and biophysical research communications.

Kinetic Studies of 25-Hydroxy-19-nor-vitamin D3 and 1α,25-Dihydroxy-19-nor-vitamin D3 Hydroxylation by CYP27B1 and CYP24A1

S. Kato, S. Ikushiro, Keiko Yamamoto, 2007, Drug Metabolism and Disposition.

Synthesis and biological activities of 14-epi-MART-10 and 14-epi-MART-11: implications for cancer and osteoporosis treatment.

Y. Harada, T. Sugiura, S. Ikushiro, 2009, Anticancer research.

Three‐step hydroxylation of vitamin D3 by a genetically engineered CYP105A1

K. Yasuda, H. Sugimoto, S. Ikushiro, 2010, The FEBS journal.

Crystal structure of CYP105A1 (P450SU-1) in complex with 1alpha,25-dihydroxyvitamin D3.

H. Sugimoto, S. Ikushiro, T. Sakaki, 2008, Biochemistry.

Protein engineering of CYP105s for their industrial uses.

K. Yasuda, H. Sugimoto, K. Yasukawa, 2018, Biochimica et biophysica acta. Proteins and proteomics.

Structure-based design of a highly active vitamin D hydroxylase from Streptomyces griseolus CYP105A1.

H. Sugimoto, S. Ikushiro, T. Sakaki, 2008, Biochemistry.

Stereoselective Glucuronidation of Propranolol in Human and Cynomolgus Monkey Liver Microsomes: Role of Human Hepatic UDP-Glucuronosyltransferase Isoforms, UGT1A9, UGT2B4 and UGT2B7

S. Narimatsu, N. Hanioka, S. Naito, 2008, Pharmacology.

Interaction of bisphenol a with human UDP‐glucuronosyltransferase 1A6 enzyme

H. Jinno, S. Narimatsu, N. Hanioka, 2008, Environmental toxicology.

Functional characterization of cynomolgus monkey UDP-glucuronosyltransferase 1A9

S. Narimatsu, N. Hanioka, Kenjiro Nagaoka, 2014, European Journal of Drug Metabolism and Pharmacokinetics.

Reading Strategies and Extensive Reading in Efl Classes

Keiko Hayashi, K. Hayashi, 1999 .